Please login to the form below

Not currently logged in
Email:
Password:

darolutamide

This page shows the latest darolutamide news and features for those working in and with pharma, biotech and healthcare.

J&J puts pressure on rivals with new Erleada okay in prostate cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer

Since then, Bayer and Orion’s  Nubeqa(darolutamide) has also joined the fray in nmCRPC after an FDA approval in July, adding to the competitive pressure in that indication.

Latest news

  • Bayer bags FDA nod for early prostate cancer drug darolutamide Bayer bags FDA nod for early prostate cancer drug darolutamide

    Meanwhile, another phase 3 clinical trial called ARASENS is ongoing and is testing darolutamide in metastatic hormone-sensitive prostate cancer (HSPC) with results due in 2022. ... Bayer says it has also submitted darolutamide in the EU, Japan, and

  • Bayer gains FDA priority review for prostate cancer drug Bayer gains FDA priority review for prostate cancer drug

    The move comes just two months after Bayer, and darolutamide-partner Orion, revealed positive late-stage data for the non-steroidal androgen receptor inhibitor. ... Darolutamide won’t have an easy time competing in against these products, however, as

  • Bayer, Orion prep challenge in prostate cancer market Bayer, Orion prep challenge in prostate cancer market

    New arrival will face tough competition, not least generic Zytiga. Bayer and Orion have put some meat on the bones of their phase 3 trial of darolutamide in non-metastatic ... The two partners released top-line results from the ARAMIS trial of

  • Bayer preps filings for new prostate cancer drug Bayer preps filings for new prostate cancer drug

    While there are already two rivals on the market, darolutamide’s developers think it has qualities which could make it a good option for patients. ... Under the terms of their 2014 agreement, Bayer has the right to commercialise darolutamide globally

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics